Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Unknown 1Completed 1

Sponsor Class

OTHER 2

Study Type

Observational 1Interventional 1

Sponsor

Conditions

Colorectal Neoplasms 449Stomach Neoplasms 295Rectal Neoplasms 271Colonic Neoplasms 192Pancreatic Neoplasms 175Neoplasm Metastasis 110Esophageal Neoplasms 88Neoplasms 68Carcinoma, Hepatocellular 60Adenocarcinoma Of Esophagus 47Adenocarcinoma 46Cholangiocarcinoma 45Lymphoma, Large B-Cell, Diffuse 44Carcinoma, Non-Small-Cell Lung 41Biliary Tract Neoplasms 38Gallbladder Neoplasms 31Gastrointestinal Neoplasms 29Recurrence 25Liver Neoplasms 25Ovarian Neoplasms 23Esophageal Squamous Cell Carcinoma 23Breast Neoplasms 22Peritoneal Neoplasms 18Bile Duct Neoplasms 17Unspecified Adult Solid Tumor, Protocol Specific 16Parkinson Disease 4, Autosomal Dominant Lewy Body 14Locally Advanced Rectal Cancer 13Head and Neck Neoplasms 13Lung Neoplasms 12Lymphoma, Non-Hodgkin 11

Interventions

Oxaliplatin 2Paclitaxel 1Hyperthermic Intraperitoneal Chemotherapy 1Cytoreduction Surgical Procedures 1Bupivacaine 1Bevacizumab 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Peritoneal Cancer × Oxaliplatin × Clear all
NCT04122885 2019-10-10

IMMUNOPAC

University Hospital Tuebingen

Unknown
60 enrolled

Peritoneal Cancer

NCT00491855 2013-01-03

Oxaliplatin and Paclitaxel Plus Bevacizumab in Advanced Peritoneal Carcinomatosis

M.D. Anderson Cancer Center

Phase 1 Completed
3 enrolled

Peritoneal Cancer

Data powered by HemOnc (CC BY 4.0) Colophon âš¡